Telehealth Visits and Remote Monitoring for Children With Type 1 Diabetes
Tests extra video visits and remote monitoring in children with type 1 diabetes.
Key facts
- Who runs it
- University of California, Davis
- Where
- Sacramento, United StatesSee the site
- Trial code
- Registry title
- Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
- Status
- Recruiting
- People taking part
- 82 people, planned
- Started
- 15 Sept 2022
- Planned end
- 1 Jul 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Supplemental video visits
- Standard of Care
- Supplemental remote monitoring
- Record updated
- 27 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teens aged 5-18 with type 1 diabetes whose blood sugar is not well controlled. It tests extra video visits and remote monitoring.
- Age
- 5-18 years
- Sex
- All sexes can join.
- Disease stage
- Type 1 diabetes for more than 12 months, with blood sugar not well controlled: HbA1c above 8% (64 mmol/mol), or a 14-day glucose management index (GMI) above 8% from continuous glucose monitoring (CGM) data, or a 14-day average blood glucose above 200 mg/dl (11.1 mmol/L) in the past month.
Main reasons for not taking part
- Home address not in California
- No internet device with video and audio
- Cannot connect the home glucose meter, CGM or insulin pump to an internet-capable device
- Not planning to receive diabetes care at the UCD Pediatric Diabetes Clinic in the next year
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- age 5-18 years
- diagnosis of type 1 diabetes with a duration of >12 months
- suboptimal glycemic control at time of enrollment, defined as a hemoglobin A1c (HbA1c) level > 8% (64 mmol/mol) or a 14-day glucose management index (GMI) of >8% from continuous glucose monitoring (CGM) data or 14-day average blood glucose of >200 mg/dl in the preceding month
- intention to receive diabetes care at the UCD Pediatric Diabetes Clinic during the following year
- access to the internet via a device with video and audio capability
- ability to connect the patient's home blood glucose meter or CGM device - as well as insulin pump, if applicable - to an internet-capable device via Bluetooth or physical cable
Who cannot take part
- -Patients whose home addresses are not in California (due to current physician licensing restrictions for telehealth services)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 5 and 18 years old?
Where in United States
- University of California - DavisSacramento, United StatesContact: Salvador Lopez, BATaking people
About the trial
What the trial wants to find out
This study will test the hypothesis that supplemental synchronous video visits and supplemental asynchronous remote monitoring can each significantly improve glycemic control for pediatric patients with uncontrolled type 1 diabetes over a 6 month period, and will compare health outcomes and patient-centered outcomes between these two intervention arms and a control arm receiving usual care.
The 3 groups in the trial
- Supplemental video visitsTreatment being tested
Participants in this intervention arm will receive home-based video visits with a pediatric endocrinologist every month for the duration of 6 months in addition to usual care.
Treatment: Supplemental video visits and Standard of Care
- Standard of CareExisting treatment, for comparison
The control group will receive usual care, consisting of quarterly visits with the UCD Pediatric Diabetes Clinic.
- Supplemental remote monitoringTreatment being tested
Participants in this intervention arm will receive remote glucose monitoring with monthly asynchronous outreach from a pediatric endocrinologist for a duration of six months in addition to usual care.
Treatment: Standard of Care and Supplemental remote monitoring
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
- Plain-language title
- Telehealth Visits and Remote Monitoring for Children With Type 1 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04428658, who can take part
- Record updated
- 27 March 2025